Effects of intravenous immunoglobulins treatment of patients with relapsing-remitting multiple sclerosis on gene expression profiles of their peripheral T-cells

被引：0
|
作者：
Pigard, N.
Kuusisto, H.
Elovaara, I.
Paalavuo, R.
Schwarz, H. P.
Reipert, B.
机构：
[1] BMT Res, Vienna, Austria
[2] Univ Tampere, Sch Med, Dept Neurol, FIN-33101 Tampere, Finland
[3] Tampere Univ Hosp, Tampere, Finland
[4] Baxter BioSci, Vienna, Austria
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2005年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：273 / 273
页数：1
相关论文
共 50 条
  • [31] Peripheral CD39-expressing T regulatory cells are increased and associated with relapsing-remitting multiple sclerosis in relapsing patients
    Nuria Álvarez-Sánchez
    Ivan Cruz-Chamorro
    María Díaz-Sánchez
    Patricia Judith Lardone
    Juan Miguel Guerrero
    Antonio Carrillo-Vico
    Scientific Reports, 9
  • [32] Gene expression predicts clinical outcome of relapsing-remitting multiple sclerosis
    Achiron, A
    Gurevich, M
    Snir, Y
    Harrai, G
    Mandel, M
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 238 : S215 - S215
  • [33] CD8+Foxp3+ T cells in peripheral blood of relapsing-remitting multiple sclerosis patients
    Frisullo, Giovanni
    Nociti, Viviana
    Iorio, Raffaele
    Plantone, Domenico
    Patanella, A. Katia
    Tonali, Pietro A.
    Batocchi, Anna Paola
    HUMAN IMMUNOLOGY, 2010, 71 (05) : 437 - 441
  • [34] Gone expression profiles of relapsing-remitting multiple sclerosis during relapse and remission
    Arthur, AT
    Booth, DR
    Bye, C
    Heard, RNS
    Stewart, GJ
    Pollard, JD
    Armati, PJ
    MULTIPLE SCLEROSIS, 2005, 11 : S112 - S112
  • [35] What is the effective dose of intravenous immunoglobulin for treatment of relapsing-remitting multiple sclerosis?
    Lewanska, M
    Siger-Zajdel, M
    Selmaj, K
    INTRAVENOUS IMMUNOGLOBULINS IN THE THIRD MILLENNIUM, 2004, : 243 - 255
  • [36] Phase II study for the treatment of relapsing-remitting multiple sclerosis patients with biomoduline T
    Lorenzo Antonio, Gamez Morales
    Lara Rodriguez Rosa, F.
    Martin Roman, Rodriguez
    Monteagudo Alina, Gonzalez-Quevedo
    Carriera Rebeca, Fernandez
    Silva Natalia, Marzoa
    REVISTA MEXICANA DE NEUROCIENCIA, 2007, 8 (01): : 28 - 31
  • [37] Longitudinal study of the in vivo effects of β-interferon-1a on dendritic cells subsets and regulatory T-cells in relapsing-remitting multiple sclerosis patients
    de Andrés, C
    Aristimuño, C
    Martínez-Ginés, ML
    de las Heras, V
    Giménez-Roldán, S
    Fernández-Cruz, E
    Sánchez-Ramón, S
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S250 - S250
  • [38] Altered microRNA expression in lymphocytes of relapsing-remitting multiple sclerosis patients
    Lindberg, Raija L.
    Hoffmann, Francine
    Kuhle, Jens
    Mehling, Matthias
    Kappos, Ludwig
    MULTIPLE SCLEROSIS, 2008, 14 : S15 - S16
  • [39] Identification of Potential Biomarkers in the Peripheral Blood Mononuclear Cells of Relapsing-Remitting Multiple Sclerosis Patients
    Golabi, Marjan
    Fathi, Farshid
    Samadi, Morteza
    Hesamian, Mohammad Sadegh
    Eskandari, Nahid
    INFLAMMATION, 2022, 45 (04) : 1815 - 1828
  • [40] T cell vaccination in multiple sclerosis relapsing-remitting nonresponders patients
    Achiron, A
    Lavie, G
    Kishner, I
    Stern, Y
    Sarova-Pinhas, I
    Ben-Aharon, T
    Barak, Y
    Raz, H
    Lavie, M
    Barliya, T
    Faibel, M
    Cohen, IR
    Mandel, M
    CLINICAL IMMUNOLOGY, 2004, 113 (02) : 155 - 160
12345